Atrium Therapeutics

Atrium is a biopharmaceutical company pioneering delivery of RNA therapeutics to the heart to transform the standard of care for people living with cardiomyopathies. Our proprietary technology leverages the targeted RNA delivery platform initially designed at Avidity, which combines the tissue selectivity of mAbs and other targeted delivery ligands with the precision of oligonucleotides.

This unique combination is designed to allow selective targeting of the underlying genetic drivers of disease that were previously undruggable. Through targeted, non-viral delivery of siRNA to cardiac tissues, our approach has the potential to overcome key limitations of nonspecific viral and nanoparticle-based delivery systems, including challenges related to tissue specificity, immunogenicity, and redosing. 

Position Overview:

Reporting directly to the Chief Strategy Officer, the Senior Director of Market Readiness & Medical Strategy is a newly created role within Atrium’s Strategy office. This person will serve as the connective tissue between medical strategy, disease ecosystem development, and market shaping — building the external stakeholder infrastructure and internal strategic frameworks needed to bring Atrium’s programs to patients.

This is a high-impact individual contributor role suited to someone who operates at the strategic level and rolls up their sleeves to execute. You will have significant autonomy, direct access to senior leadership, and the opportunity to build programs that define how Atrium shows up in the rare cardiomyopathy field.

At Atrium, we move with urgency and intellectual rigor, and we believe that AI-augmented ways of working are not a future ambition but a present standard. Every member of our team is expected to embrace emerging tools and technologies as a natural part of how we think, research, and execute

Responsibilities:

Education & Experience Requirements:

• 12+ years of biopharma experience with a strong foundation in Medical Affairs and a demonstrated ability to think and operate with strategic breadth
• Experience in rare disease is required; rare cardiomyopathy or cardiovascular genetics experience is a strong plus
• Proven track record building KOL networks, driving publication strategy, and leading congress planning
• Comfortable operating as an individual contributor in a lean, resource-constrained environment, a builder who creates structure where none exists
• Strong cross-functional influencing skills; good collaborator in a matrix organization, able to operate at the intersection of science, strategy, and execution without formal authority
• Advanced degree (MD, PharmD, PhD, or MBA) preferred; exceptional candidates with MS and deep rare disease experience will be considered
• 50% travel expected

What we Provide: 
• The base salary range for this role is $275,000 - $305,000 The final compensation will be commensurate with such factors as relevant experience, skillset, internal equity and market factors.
• Atrium offers competitive compensation and benefits which include stock options & RSUs, as well as a 401(k) with an employer match. In addition, the comprehensive wellness program includes coverage for medical, dental, vision, LTD, and unlimited of time off including summer & winter breaks.
• A commitment to learning and development which includes a variety of programming internally developed by and for Atrium employees, opportunities for job-specific training offered by industry, and an education reimbursement program.

We may use artificial intelligence (AI) tools to support parts of the hiring process, such as reviewing applications, analyzing resumes, or assessing responses. These tools assist our recruitment team but do not replace human judgment. Final hiring decisions are ultimately made by humans. If you would like more information about how your data is processed, please contact us.